News headlines about BIO-key International (NASDAQ:BKYI) have trended somewhat positive on Tuesday, Accern reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. BIO-key International earned a news impact score of 0.14 on Accern’s scale. Accern also gave headlines about the technology company an impact score of 47.3134377786014 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of BIO-key International (BKYI) traded down $0.04 during midday trading on Tuesday, hitting $1.79. The stock had a trading volume of 800 shares, compared to its average volume of 9,536. BIO-key International has a one year low of $1.56 and a one year high of $3.67.

BIO-key International (NASDAQ:BKYI) last announced its earnings results on Monday, August 14th. The technology company reported ($0.32) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.22) by ($0.10). The firm had revenue of $0.89 million for the quarter. BIO-key International had a negative return on equity of 58.24% and a negative net margin of 201.76%.

TRADEMARK VIOLATION WARNING: “BIO-key International (BKYI) Earning Somewhat Favorable Media Coverage, Analysis Shows” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be accessed at

In related news, insider Fong Wong Kwok purchased 427,778 shares of BIO-key International stock in a transaction that occurred on Friday, September 22nd. The shares were acquired at an average price of $3.60 per share, with a total value of $1,540,000.80. Following the completion of the transaction, the insider now directly owns 1,781,815 shares of the company’s stock, valued at approximately $6,414,534. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 11.40% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver’s licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing.

Receive News & Ratings for BIO-key International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.